Answers are grounded in this paper and cite their sources.
Description Microbial metabolites identified in animal models and human neurological diseases could be therapeutic targets From the discovery of roles of the gut microbiota in metabolic disorders such as obesity (1) to recent discoveries of gut microbiota modulating responses to cancer immunotherapy (2), microbiome research has expanded to all areas of biomedical research over the past 15 years. A vital role for gut microbiota–brain communication in brain development, behavior, and function has emerged (3). Research using germ-free mice has played a considerable role in identifying brain systems that may be regulated by microbiota, including blood-brain barrier permeability, brain volume, neural circuitry, myelination, and alterations in microglia (3). Microbial-derived molecules, including neurotransmitters, short-chain fatty acids, bile acids, lactate, and vitamins, exert local effects in the gastrointestinal environment but can also enter the circulation to act at remote sites, including the brain (4). Recent efforts to translate preclinical findings in amyotrophic lateral sclerosis (ALS) and autism spectrum disorder (ASD) to the clinic highlight the potential for clinically important discoveries in microbiota–brain research (5–7).
No takes yet. Share an insight, caveat, or question.
Jane A. Foster (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: